DNMT3B7 disrupts embryonic development and accelerates lymphomagenesis
Source: NCBI BioProject (ID PRJNA126263)
Source: NCBI BioProject (ID PRJNA126263)
0 0
Project name: Mus musculus
Description: Cancer cells have an altered distribution of DNA methylation and express aberrant DNA methyltransferase 3B transcripts, which encode truncated proteins. To test if a truncated DNMT3B isoform disrupts DNA methylation in vivo, we constructed transgenic mice expressing DNMT3B7, a common truncated DNMT3B isoform in cancer cells. DNMT3B7 transgenic mice exhibit altered embryonic development, including lymphopenia, craniofacial abnormalities, and cardiac defects, similar to Dnmt3b-deficient animals, but rarely develop cancer. However, DNMT3B7 expression increases the frequency of mediastinal lymphomas in Eμ−myc animals. Eμ-myc/DNMT3B7 lymphomas have more chromosomal rearrangements, increased global methylation levels, and more locus-specific perturbations in DNA methylation patterns compared to Eμ-myc lymphomas. Our results demonstrate that a truncated DNMT3B protein can alter tumorigenesis, suggesting a similar role in human tumors.Overall design: Direct comparison of DNA methylation in lymphoma samples from Eu-Myc vs Eu-Myc/Dnmt3b7 mice.
Data type: Epigenomics
Sample scope: Multiisolate
Relevance: ModelOrganism
Organization: Maria Figueroa, Pathology, University of Michigan
Literatures
- PMID: 20587527
Release date: 2010-07-30
Last updated: 2010-04-08